Artery Therapeutics Inc. Company
Artery Therapeutics, Inc. (Artery), a biotechnology company headquartered in the San Francisco Bay area, develops proprietary therapeutics for cardiovascular disease (CVD). Now Artery is applying its technical and metabolic know-how to developing treatments for diabetes-generated cardiovascular disease and neurodegenerative diseases.
Industry:
Geroscience
Headquarters:
Danville, California, United States
Zip:
1-10
Employees Number:
1-10
Total Funding:
$1M to $10M
Estimated Revenue:
$1M to $10M
Register and Claim Ownership